AU2002334836B2 - N-heterocyclyl hydrazides as neurotrophic agents - Google Patents
N-heterocyclyl hydrazides as neurotrophic agents Download PDFInfo
- Publication number
- AU2002334836B2 AU2002334836B2 AU2002334836A AU2002334836A AU2002334836B2 AU 2002334836 B2 AU2002334836 B2 AU 2002334836B2 AU 2002334836 A AU2002334836 A AU 2002334836A AU 2002334836 A AU2002334836 A AU 2002334836A AU 2002334836 B2 AU2002334836 B2 AU 2002334836B2
- Authority
- AU
- Australia
- Prior art keywords
- compound
- disease
- condition
- heterocyclyl
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32701901P | 2001-10-04 | 2001-10-04 | |
| US60/327,019 | 2001-10-04 | ||
| PCT/US2002/031678 WO2003029247A1 (en) | 2001-10-04 | 2002-10-04 | N-heterocyclyl hydrazides as neurotrophic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002334836A1 AU2002334836A1 (en) | 2003-06-26 |
| AU2002334836B2 true AU2002334836B2 (en) | 2008-04-17 |
Family
ID=23274781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002334836A Expired - Fee Related AU2002334836B2 (en) | 2001-10-04 | 2002-10-04 | N-heterocyclyl hydrazides as neurotrophic agents |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7087628B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1448553B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005506335A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE294794T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2002334836B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2462419A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60204046T2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2242096T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA04003216A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003029247A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1918286B1 (en) * | 2006-11-05 | 2011-12-21 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Thiazolhydrazides for treatment of neurodegenerative diseases |
| WO2012027548A1 (en) * | 2010-08-25 | 2012-03-01 | The Feinstein Institute For Medical Research | Compounds and methods for prevention and treatment of alzheimer's and other diseases |
| EP3515427A4 (en) | 2016-09-26 | 2020-10-14 | Qingdao Primedicine Pharmaceutical Co., Ltd | N-METHYL D-ASPARTATE RECEPTOR ALLOSTERIC MODULATORS AND METHODS FOR USING THEM |
| PL233208B1 (pl) * | 2018-09-17 | 2019-09-30 | Politechnika Wroclawska | Iminowe pochodne aldehydów salicylowych i hydrazydu kwasu 4-hydroksybenzoesowego oraz sposób ich wytwarzania |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4665173A (en) * | 1982-03-31 | 1987-05-12 | Klayman Daniel L | 2-acetyl- and 2-propionylpyridine selenosemicarbazones |
| US4694004A (en) * | 1984-07-09 | 1987-09-15 | Fujisawa Pharmaceutical Co., Ltd. | Semicarbazide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same |
| ES2161594B1 (es) * | 1998-12-17 | 2003-04-01 | Servier Lab | Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. |
| US6544976B1 (en) | 1999-07-09 | 2003-04-08 | Ortho-Mcneil Pharmaceutical, Inc. | Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods |
| US6323215B1 (en) | 1999-07-09 | 2001-11-27 | Ortho-Mcneil Pharmaceutical, Inc. | Neurotrophic tetrahydroisoquinolines and tetrahydrothienopyridines, and related compositions and methods |
| HUP0304058A2 (hu) * | 2001-01-30 | 2004-04-28 | Bristol-Myers Squibb Company | Xa faktor szulfonamid-laktám inhibitorok és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények |
-
2002
- 2002-10-04 JP JP2003532495A patent/JP2005506335A/ja active Pending
- 2002-10-04 AT AT02800473T patent/ATE294794T1/de not_active IP Right Cessation
- 2002-10-04 EP EP02800473A patent/EP1448553B1/en not_active Expired - Lifetime
- 2002-10-04 ES ES02800473T patent/ES2242096T3/es not_active Expired - Lifetime
- 2002-10-04 US US10/264,997 patent/US7087628B2/en not_active Expired - Lifetime
- 2002-10-04 CA CA002462419A patent/CA2462419A1/en not_active Abandoned
- 2002-10-04 DE DE60204046T patent/DE60204046T2/de not_active Expired - Lifetime
- 2002-10-04 AU AU2002334836A patent/AU2002334836B2/en not_active Expired - Fee Related
- 2002-10-04 WO PCT/US2002/031678 patent/WO2003029247A1/en not_active Ceased
- 2002-10-04 MX MXPA04003216A patent/MXPA04003216A/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| ATE294794T1 (de) | 2005-05-15 |
| CA2462419A1 (en) | 2003-04-10 |
| ES2242096T3 (es) | 2005-11-01 |
| EP1448553B1 (en) | 2005-05-04 |
| MXPA04003216A (es) | 2005-01-25 |
| JP2005506335A (ja) | 2005-03-03 |
| DE60204046D1 (de) | 2005-06-09 |
| US20030144262A1 (en) | 2003-07-31 |
| DE60204046T2 (de) | 2006-01-19 |
| US7087628B2 (en) | 2006-08-08 |
| HK1066223A1 (en) | 2005-03-18 |
| WO2003029247A1 (en) | 2003-04-10 |
| EP1448553A1 (en) | 2004-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6622824B2 (ja) | キヌレニン−3−モノオキシゲナーゼインヒビターおよびその医薬組成物ならびにこれらの使用方法 | |
| EP2964223B1 (en) | Compounds inhibiting leucine-rich repeat kinase enzyme activity | |
| KR102204804B1 (ko) | 디히드로피라졸 gpr40 조절제 | |
| CN112312904A (zh) | 螺环化合物 | |
| JP2021534106A (ja) | Pad4阻害剤としての置換チエノピロール | |
| TW201706265A (zh) | 做為Rho激酶(ROCK)抑制劑之內醯胺 | |
| EP2257340A2 (en) | Compounds for treating muscular dystrophy | |
| CN102264740A (zh) | 一种吡咯[1,2-b]哒嗪衍生物及其作为hif调节剂的用途 | |
| EP3681877B1 (en) | Pyrazole derivative compound and use thereof | |
| JP2014511355A (ja) | ヒストンデアセチラーゼ阻害薬並びにその組成物及び使用方法 | |
| WO2020233618A1 (zh) | 一类细胞程序性坏死抑制剂及其制备方法和用途 | |
| CN106068265A (zh) | 用于治疗代谢病症的二氢吡啶酮mgat2抑制剂 | |
| EP1448553B1 (en) | N-heterocyclyl hydrazides as neurotrophic agents | |
| AU2002334836A1 (en) | N-heterocyclyl hydrazides as neurotrophic agents | |
| CN112703187A (zh) | 作为trk受体的调节剂的4-取代的苯基-1,3,5-三嗪衍生物 | |
| WO2016112863A1 (zh) | N-取代-3,5-二取代苯甲酰胺类化合物及其制备方法和应用 | |
| EP1446127B1 (en) | Triazepine derivatives as neurotrophic agents | |
| US6821993B1 (en) | Triazepine derivatives as neurotrophic agents | |
| HK1066223B (en) | N-heterocyclyl hydrazides as neurotrophic agents | |
| AU2002334837A1 (en) | Triazepine derivatives as neurotrophic agents | |
| WO2001004091A1 (en) | Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods | |
| HK40085749A (en) | P2x3 modulators | |
| WO2024153237A1 (zh) | 一种igf-1r酪氨酸激酶抑制剂、药物组合物及其用途 | |
| WO2024067566A1 (zh) | 饱和环类衍生物、包含其的药物组合物及其医药用途 | |
| EP1842845A1 (en) | Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE APPLICANT/PATENTEE FROM ORTHO MC NEIL PHARMACEUTICAL, INC. TO ORTHO-MCNEIL PHARMACEUTICAL, INC. |
|
| PC1 | Assignment before grant (sect. 113) |
Free format text: FORMER APPLICANT(S): (25D) 2002341563 (25D) 2002344676 (5C) 2005201131 TRAILERS BY DESIGN PTY LTD THE APPLICATION HAS BEEN |